Rixubis (coagulation factor IX (recombinant human)) 1 UNT Injection
- RxCUI
- 1666314
- RxNorm name
- Rixubis (coagulation factor IX (recombinant human)) 1 UNT Injection
- Display name
- Rixubis (coagulation factor IX (recombinant human)) 1 UNT Injection
- Full name
- Rixubis (coagulation factor IX (recombinant human)) 1 UNT Injection
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:28
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 125446 | Rixubis | Coagulation Factor IX (Recombinant) | 351(a) | Rx | 2026-09-01 |
UNII Substances#
No records found.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| f5070a92-96b8-476a-a2dc-18b22d95e5e0 | RIXUBIS 1 UNT Injection [PSN] · nonacog alfa 1 UNT Injection [Rixubis] [SBD] · Rixubis (coagulation factor IX (recombinant human)) 1 UNT Injection [SY] | 3 | 14 | These highlights do not include all the information needed to use RIXUBIS ® safely and effectively. See full prescribing information for RIXUBIS. RIXUBIS [Coagulation Factor IX (Recombinant)] For Intravenous Injection, Lyophilized Powder for Solution Initial U.S. Approval: 2013 | 20260512 |